Apyx Medical Corporation

US$2.93As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:APYXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.11%)
Div yield —
ROE (102.51%)
Medical Devices
Beta (5Y) 1.46
PE TTM —
TSR TTM (3.30%)
Mkt cap US$123.4M
ROIC (4.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.66
24.75%
(57.05%)
Hold 9|5|6|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.07
32.35%
25.02%
21.30%
12.93%
Revenue$M
11.90
12.00
11.90
11.65
1.39%
3.00%
2.42%
(2.83%)
Peers (US$123.4M)
Cap (US$)
PE
130.0M
—
121.9M
—
Capital
TTM
5Y
10Y
Leveragex
4.091
(0.021)
(0.025)
EBIT/Intx
0.259
0.928
0.737
Own earn%
80.88
123.31
119.48
Sh yield%
15.48
36.25
32.97
Owners
Insiders/Inst%
6.73
24.02
Short interest%
3.36
SBC / revenue%
4.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
14–21
$1 testx
—
Incr. ROIC%
5